US · Healthcare

Axsome Therapeutics Inc (AXSM)

Biotechnology

Axsome Therapeutics Inc (AXSM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AXSM

P/E ratio

18.00

Axsome Therapeutics Inc (AXSM) — FAQ

What is AXSM's P/E ratio?

The price-to-earnings (P/E) ratio for Axsome Therapeutics Inc (AXSM) is 18.00 (data as of 2026-03-23).

Does Axsome Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Axsome Therapeutics Inc (AXSM). Check the MyAverix Finance app for the latest dividend data.

What sector is Axsome Therapeutics Inc in?

Axsome Therapeutics Inc (AXSM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AXSM listed on?

AXSM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)